Minutes matter when a surgeon is deciding how much tissue to remove. Yet for centuries, medical imaging has leaned on stains ...

Researchers at UBC Okanagan have made two major discoveries that are set to revolutionize how scientists observe and measure molecular forces within living cells. Published recently in two ...

A new molecular imaging agent can accurately identify a crucial biomarker found among many different types of cancer. Precise visualization of the trophoblast cell surface antigen 2 (Trop2) biomarker ...

Radiopharmaceutical therapy and molecular imaging—together known as Theranostics—are gaining significant traction worldwide. Even though Theranostics dates back to the early 1940s, a rapid expansion ...

Novel approaches in molecular imaging and targeted therapeutics are transforming the management of renal cell carcinoma (RCC) and urothelial carcinoma (UC). This review focuses on three key areas of ...

Transitioning molecular imaging from a preclinical technique to a standard clinical tool could help detect the very earliest stages of disease, reports Tami Freeman Tools of the trade Left: this ...

Highly comparable biodistribution profiles of Radio-DARPin candidates labeled with imaging isotopes 177Lu or 203Pb allows for rapid expansion of ...

BERLIN & NAPLES, Fla.--(BUSINESS WIRE)--Bayer, a leading company in key areas of radiology and cardiology, and Attralus, Inc. (Attralus), a clinical stage biopharmaceutical company focused on ...

Opportunities in the Middle East imaging biomarkers market include the expansion of advanced imaging infrastructure and increased adoption of biomarker-driven clinical pathways. Driven by rising ...